Coronary microvascular reactivity to sympathetic stimulation in patients with idiopathic dilated cardiomyopathy

Journal of Nuclear Medicine

Volumn 41, Issue 5, 2000, Pages 837-844

  Drzezga, Alexander E ^a   Blasini, Rudolf ^a   Ziegler, Sybille I ^a   Bengel, Frank M ^a   Picker, Wolfgang ^a   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cold pressor test; Idiopathic dilated cardiomyopathy; PET

Indexed keywords

ADRENERGIC STIMULATION; ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; COLD PRESSOR TEST; CONGESTIVE CARDIOMYOPATHY; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BLOOD PRESSURE; CARDIOMYOPATHY, DILATED; COLD; CORONARY CIRCULATION; CORONARY VESSELS; FEMALE; HEART RATE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; SYMPATHETIC NERVOUS SYSTEM; TOMOGRAPHY, EMISSION-COMPUTED; VASCULAR RESISTANCE;

EID: 0034101962     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Treasure CB, Vita JA, Cox DA, et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 1990;81:772-779.
2. Inoue T, Sakai Y, Morooka S, et al. Coronary flow reserve in patients with dilated cardiomyopathy. Am Heart J. 1993;125:93-98.
3. Cannon RO, Cunnion RE, Parillo JE, et al. Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. J Am Coll Cardiol. 1987;10:1190-1200.
4. Holdright DR, Clarke D, Fox K, Poole Wilson PA, Collins P. The effects of intracoronary substance P and acetylcholine on coronary blood flow in patients with idiopathic dilated cardiomyopathy. Eur Heart J. 1994;15:1537-1544.
5. Inoue T, Sakai Y, Morooka S, et al. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy. Am Heart J. 1994;127:376-381.
6. Bach DS, Beanlands RS, Schwaiger M, Armstrong WF. Heterogeneity of ventricular function and myocardial oxidative metabolism in nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 1995;25:1258-1262.
7. Neglia D, Parodi O, Gallopin M, et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by position emission tomography. Circulation. 1995;92:796-804.
8. Spinale FG, Tanaka R, Crawford FA, Zile MR. Changes in myocardial blood flow during development of and recovery from tachycardia induced cardiomyopathy. Circulation. 1992;85:717-729.
9. Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol. 1989;14:1181-1190.
10. Gelbhard AS, Benua RS, Reimann RE, McDonald JM, Vomero JJ, Laughlin JS. Imaging of the human heart after administration of L-(N-13)glutamate. J Nucl Med. 1980;21:988-991.
11. Muzik O, Beanlands R, Wolfe E, Hutchins GD, Schwaiger M. Automated region definition for cardiac nitrogen 13-ammonia PET imaging. J Nucl Med. 1993;34: 336-344.
12. Muzik O, Beanlands RS, Hutchins GD, Mangner TJ, Nguyen N, Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 1993;34:83-91.
13. Hutchins GD, Caraher JM, Raylman RR. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med. 1992;33:1243-1250.
14. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Scheibert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990;15:1032-1042.
15. Czernin J, Muller P, Chan S, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation. 1993;88:62-69.
16. Nitenberg A, Foult JM, Blanchet F, Zouioueche S. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy. Am J Cardiol. 1985;55:748-754.
17. Parodi O, De Maria R, Oltrona L, et al. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation. 1993;88:509-522.
18. DeMarco T, Kanu Ch, Rouleau JL, Parmley W. Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J. 1988;115:809-815.
19. Beanlands R, Armstrong WF, Hicks R, et al. The effects of afterload reduction on C11-acetate kinetics in patients with dilated cardiomyopathy. J Nucl Cardiol. 1994;1:3-16.
20. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation. 1988;77:43-52.
21. Di Carli MF, Tobes MC, Levine AB, et al. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med. 1997;336:1208-1215.
22. Cocks TM, Angus JA. Endothelium dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 1983;305:627-630,
23. Lehmann M, Hasenfuss G, Samek L, Gastmann M. Catecholamine metabolism in heart failure patients and healthy control subjects. Arzneimittelforschung 1990;40: 1310-1318.
24. Katz SD, Biasucci L, Sabba C, et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol. 1992;19:918-925.
25. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 1993;92:652-662.
26. Sonnenblick EH, Factor SM, Strobeck JE, Capasso J, Fein F. The pathophysiology of heart failure: the primary role of microvascular hyperreactivity and spasm in the development of congestive cardiomyopathies. In: Braunwald E, Mock MB, Watson J, eds. Congestive Heart Failure: Current Research and Clinical Applications. New York, NY: Grune & Stratton; 1982:87.
27. Drexler H, Zeiher AM, Wollschlager H, Meinertz T, Just H, Bonzel T. Flow-dependent coronary artery dilatation in humans. Circulation. 1989;80:466-474.
28. Carrier GO, White RE. Enhancement of alpha 1 and alpha 2 adrenergic agonist induced vasoconstriction by removal of endothelium in rat aorta. J Pharmacol Exp Ther. 1985;232:682-687.
29. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;373-376.
30. Ontkean MT, Gay RG, Lewis HS, Greenberg BH. Diminished endothelium derived relaxing factor (EDRF) activity in heart failure [abstract]. Circulation. 1989;80(suppl):11436.
31. Campisi R, Czernin J, Schöder H, et al. Effects of long-term smoking on myocardial blood flow, coronary vasomotion and vasodilator capacity. Ciriculation 1998;98:119-125.
32. Bohm M, Gierschik P, Jakobs KH, et al. Localization of a "postreceptor" defect in human dilated cardiomyopathy. Am J Cardiol. 1989;64:812.
33. Feldmann AM, Cates AE, Veazy WB, Hershberger RE, Bristow MR, Baughmann KL. Increase of the 40,000 mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest. 1988;82:189-197.
34. Bristow MR, Ginsburg R, Fowler M, et al. β1 and β2-adrenergic receptor surpopulations in normal and failing human ventricular myocardium. Circ Res. 1986;59:297-309.
35. Hirooka Y, Imaizumi T, Harada S, et al. Endothelium dependent forearm vasodilation to acetylcholine but not to substance P is impaired in patients with heart failure. Cardiovasc Pharm. 1992;20(suppl):S221-S225.
36. Dobnig H, Leb G, Lipp R, et al. Sulfoconjugated and free plasma catecholamine levels at rest and during exercise in patients with idiopathic dilated cardiomyopathy. Eur J Endocrinol. 1995;132:181-191.
37. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against beta adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res. 1989:64-97.
38. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow M. Assessment of the β adrenergic receptor pathway in the intact and the failing human heart: progressive receptor down-regulation and suhsensitivity to agonist response. Circulation. 1986;74:1290-1302.
39. Gustavsson CG, Persson SU, Larsson H, Persson S. Changed blood theology in patients with idiopathic dilated cardiomyopathy. Angiology. 1994;45:107-111.
40. Braunwald E, Wynne J. The cardiomyopathies and myocarditides: toxic, chemical and physical damage to the heart. In: Braunwald E, ed. Heart Disease. 4th ed. Philadelphia, PA: WB Saunders; 1992:1394-1412.